ReviewPharmacoEconomics2016

The Clinical and Cost Effectiveness of Ustekinumab for the Treatment of Psoriatic Arthritis: A Critique of the Evidence.

Joanne O'Connor et al.PubMed ↗Publisher ↗

No numbers read from the abstract.